Beruflich Dokumente
Kultur Dokumente
201 Risin
R ng Sttarss
Miicroequ
uitie
es Conf
C fere
ence
e
2010 RISING STARS MICROCAP CONFERENCE
Thursday 10 of June 2010 / Level 4– Room 1/ SYDNEY HILTON (488 George St, NSW 2000)
AGENDA
MORNING SESSION
AFTERNOON SESSION
www.microequities.com.au
2010 RISING STARS MICROCAP CONFERENCE
PROFILES
EVENT ORGANISER
Why us? Microequities' investment managers and analysts operate uniquely within the Microcap
asset class. This asset class offers investors access to Australian companies with an attractive
growth profile. However, it also necessitates a systematic and process driven research approach
to investing. We are uniquely positioned within the Microcap asset class and posses research
capabilities, deep knowledge and experience within the Microcap space. Our value-growth
approach, coupled with a long term investment strategy, provides us with an investment ethos
that is particularly well suited to Microcap investing.
The Deep Value Microcap Fund: Launched in March 2009, is a high conviction, value growth
Fund that seeks to identify and invest in growing, profitable undervalued companies. The Fund
does not have a broad based approach to investment. It maintains concentrated holdings in what
we consider the most compelling companies within the Microcap asset class with the most
attractive risk/reward metrics. The fund has returned 83% since inception (net of fees) compared
to 43.12% for the All Ords Index.
EVENT SPONSOR
Fortbridge Consulting is a media and investor relations firm representing publicly listed
companies. Fortbridge works with their clients to build corporate reputation and promote value.
With access to up-to-date research and investor contact information for financial centers around
the world, Fortbridge is able to research and maintain meaningful sector specific investor lists for
their clients. Using this information, Fortbridge target relevant institutional investors and funds to
engage their support for their clients’ IPOs, institutional placements, capital raisings, SPPs or
on-market trades.
Fortbridge consultants in Sydney, Perth, London Toronto and Santiago have a track-record in
working with clients to build shareholders value and to grow business; to communicate the value
of new developments and to manage significant issues that impact reputation.
XRF SCIENTIFIC LIMITED
ASX‐XRF
Presented by
Terry Sweet (Managing Director)
Introduction
• XRF is a leading Australian supplier of products and services
which facilitate the analysis of minerals and materials
which facilitate the analysis of minerals and materials
• XRF manufacturers and markets specialized equipment,
consumables and technical support services
• XRF primarily services the resources and analytical industries
– domestically and worldwide through our distributor
y g
network
The Vital Link in
Mining and Industrial Analysis
XRF Scientific Products
Consumables
• Fusion fluxes with at least 50% Australian market share
• Platinum labware with at least 65% Australian market share
• Regular supply of consumable products offer unique
pp y
opportunity to secure future sales of both consumables and
high value capital equipment to customers
XRF Scientific Products
Capital Equipment
• Full range of fusion machine configurations from basic
manual operation through to full fledged high throughput
robotic systems using both electric and gas technologies.
• Dominant supplier of gas fusion technology in Australia and
worldwide.
• Dominant supplier of electric fusion technology in Australia
and now have exclusive worldwide supply agreement to
PANalytical of latest generation cold to cold electric fusion
machines.
Market Position
• Well recognised and respected brands
• Well‐established market base
• Specialised patented technologies
• Highly qualified management team
• Strong presence in Australia; facilities in Perth and Melbourne
• Strategic alliance with PANalytical
• Global network of distributors
Our Customers
• Specialised markets: mining, cement, steel, paper,
plastics, glass and ceramics
• Multinational blue‐chip customers in the resources
sector: BHP Billiton, Rio Tinto, Iluka, Xstrata and Alcoa
• Major commercial laboratories and scientific
enterprises: CSIRO
i CSIRO
Earnings
Consolidated Balance Sheet 31 Dec 09
($000)
Cash 4,451
Total Assets 16,598
Total Liabilities* 1,972
Net Assets 14,626
NTA per share 9.4 cents
* Trade liabilities only – No Debt
FY10 Outlook and Beyond
• Even with full impact of GST, still profitable and cash flow +ve
• Evidence that GFC induced downward trend has reversed
• Sales of consumables have reverted to normal
• Enquiries for capital equipment are stronger
• Mining groups shipping increasing tonnages
• Base metals prices e.g. nickel, again buoyant
• PANalytical sales gaining traction
Investment Case
• Profitable and cash flow positive
• Well established in niche marketplace
• Multinational blue‐chip customer base
• Patented proprietary technologies
• Majority of revenues from repeat business
• Strong balance sheet, cash reserves of $4.5m, no debt
Strong balance sheet cash reserves of $4 5m no debt
• Significant growth opportunities – market growth, cross selling
(incl. international) and active pursuit of M&A targets
Capital Structure
Current Share Price $0.16
Market Capitalisation $14.7m
Unlisted Options (ex 16‐20c, exp 2010) 9.3m
Directors %
23.8%
Top 20 54.7%
Share Price
Contact Details
XRF Scientific Limited
XRF Scientific Limited
Terry Sweet
(08) 9244 9600
terry.sweet@xrfscientific.com
K S Capital Pty Limited
Greg Wood
(02) 9295 9826
g.wood@kscapital.com.au
Disclaimer
Any statements, opinions, projections, forecasts or other material contained in this document do not constitute any
commitments, representations or warranties by XRF or K S Capital Pty Ltd or its directors, agents and employees. Except
as required by law, and only to the extent so required, directors, agents and employees of XRF or K S Capital Pty Ltd shall
in no way be liable to any person or body for any loss, claim, demand, damages, costs or expenses of whatsoever nature
arising in any way out of, or in connection with the information contained in the document.
This document includes certain statements, opinions, projections, forecasts and other material, which reflect various
assumptions. The assumptions may or may not prove to be correct. Recipients of the document must make their own
independent investigations, consideration and evaluation of the Company before any investment decision is made. By
accepting this
h document
d the
h recipient agrees that
h iff it proceeds
d further
f h with h its investigations, consideration
d or
evaluation of the opportunity to invest in the Company it shall make and rely solely upon its own investigations and
inquiries and will not in any way rely upon the document.